Nitrofurantoin Dosage and Frequency for Urinary Tract Infections
For uncomplicated urinary tract infections (UTIs), nitrofurantoin should be dosed at 100 mg orally every 6 hours for treatment of UTIs due to vancomycin-resistant Enterococcus (VRE), or 100 mg twice daily for 5-7 days for standard uncomplicated UTIs. 1
Dosing Recommendations by Indication
Uncomplicated UTIs in Women
- Nitrofurantoin monohydrate/macrocrystals: 100 mg orally twice daily for 5-7 days 1
- Clinical efficacy rate: 93% (range 84-95%)
- Microbiological efficacy rate: 88% (range 86-92%)
- Common side effects: nausea, headache
UTIs due to Vancomycin-Resistant Enterococcus (VRE)
- Nitrofurantoin: 100 mg orally every 6 hours 1
Evidence for Efficacy
Randomized controlled trials have demonstrated that nitrofurantoin is significantly more effective than placebo in achieving both symptomatic relief and bacteriological cure 3
- After 3 days: 27/35 combined symptomatic improvement/cure with nitrofurantoin vs. 19/35 with placebo
- Bacteriological cure after 3 days: 21/26 with nitrofurantoin vs. 5/25 with placebo
Nitrofurantoin (100 mg twice daily for 5 days) has shown equivalent clinical and microbiological cure rates to trimethoprim-sulfamethoxazole (160/800 mg twice daily for 3 days) 1
In a study comparing nitrofurantoin (50 mg four times daily for 7 days) with single-dose fosfomycin (3 g), clinical and bacteriological cure rates were not significantly different, though more early side effects were reported with fosfomycin 4
Pediatric Dosing
Important Clinical Considerations
- Nitrofurantoin is not recommended for pyelonephritis or perinephric abscess 1
- Recommended treatment duration is 7 days or at least 3 days after obtaining a sterile urine 1
- Recent UK guidelines recommend 3-day courses of nitrofurantoin (100 mg twice daily), though evidence directly supporting this shorter duration is limited 5
- Nitrofurantoin should be taken with food to improve absorption and reduce gastrointestinal side effects 6
Monitoring and Follow-up
- Clinical response should be expected within 3 days of treatment initiation 3
- If symptoms persist beyond 3 days, consider alternative diagnosis or resistant organism 1
- Routine post-treatment urinalysis or urine cultures are not indicated for asymptomatic patients 2
Contraindications
- Not recommended in patients with creatinine clearance <30 mL/min 7
- Use with caution in patients with G6PD deficiency due to risk of hemolysis 7
- Not recommended for use in the last trimester of pregnancy due to risk of hemolytic anemia in the newborn 7
Nitrofurantoin remains an important first-line agent for uncomplicated UTIs due to its continued effectiveness against most uropathogens and low rates of resistance development 6, 7.